Prospect: information for the patient
Paliperidone TAD3 mg prolonged-release tablets EFG
Paliperidone TAD6 mg prolonged-release tablets EFG
Paliperidone TAD9 mg prolonged-release tablets EFG
Read this prospect carefully before starting to take this medicine, as it contains important information for you.
-Keep this prospect, as you may need to read it again.
-If you have any doubts, consult your doctor or pharmacist.
-This medicine has been prescribed only for you, and you should not give it to other people even if they have the same symptoms as you, as it may harm them.
1.What is Paliperidone TAD and what it is used for
2.What you need to know before starting to take Paliperidone TAD
3.How to take Paliperidone TAD
4.Possible adverse effects
5.Storage of Paliperidone TAD
6.Contents of the pack and additional information
Paliperidone contains the active ingredient paliperidone, which belongs to the class ofmedicamentosantipsicóticos.
Paliperidone is used to treat schizophrenia in adults and adolescents aged 15 years and older.
Schizophrenia is a disorder that causes symptoms that include hearing, seeing or feeling things thatdonotexist, holding false beliefs, having an abnormal distrust, becoming withdrawn, speaking incoherently and flattening of behavior and emotion. People with this disorder may also feel depressed, anxious, guilty ortense.
Paliperidone is also used to treat schizoaffective disorder inadultos.
Schizoaffective disorder is a mental condition in which the person experiences several of the symptoms of schizophrenia (listed in the previous paragraph) in addition to symptoms of mood disorder (feeling of euphoria, sadness, agitation, being distracted, insomnia, loquacity, loss of interest in daily activities, excessive or inadequate sleep, excessive or inadequate food intake, and recurring thoughts ofsuicidio).
Paliperidone may help alleviate the symptoms of your illness and prevent it fromreaparezcan.
Do not takepaliperidone
-if you are allergic to paliperidone, risperidone, or any of the other ingredients in thismedicine(listed in section6)
Warnings andprecautions
Consult your doctor or pharmacist before starting to take paliperidone..
If you have any of these conditions, please consult your doctor as it may benecessaryor a dose adjustment or monitoring during atimepo.
Because, in very rare cases, a dangerously low number of a type of white blood cells necessary to fight infections in the blood has been observed in patients treated with paliperidone, your doctor may check the number of white blood cells.
Paliperidone may cause you to gain weight. A significant weight gain canafectarnegatively on your health. Your doctor will regularly monitor yourweight.
In patients treated with paliperidone, diabetes mellitus or worsening of existing diabetes mellitus has been observed. Your doctor should check for signs of increased blood sugar.In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.
During eye surgery for cataracts, the pupil (the small circle in the middle of the eye) may not dilate as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery and this may cause eye damage.If you are planning to have eye surgery, be sure to inform your ophthalmologist thatyouareusing thismedicine.
Children andadolescents
Paliperidone should not be administered to children and adolescents under 15 years old for the treatment ofschizophrenia.
Paliperidone should not be administered to children and adolescents under 18 years old for the treatment ofschizoaffectivedisorderos.
This is because it is unknown whether paliperidone is safe or effective in this agegroup.
Other medications and paliperidone
Inform your doctor or pharmacist if you are using, have used recently, or may need to use anyothermedicines.
Abnormalities in heart function may occur when this medication is taken with other medications for heart rhythm control or other medications such as antihistamines, antimalarials, orantipsicótics.
Since this medication primarily acts on the brain, this medication may interfere with other medications (or alcohol) that also act on it, due to the sum of effects onbrainfunction.
This medication may lower blood pressure, so you should be careful if you take this medication with other medications that alsoreducebloodpressure.
This medication may reduce the effect of medications for Parkinson's disease and restless legs syndrome (e.g.,levodopa).
The effects of this medication may be affected if you take medications that influence the speed of intestinal movement (e.g.,metoclopramidas).
Consider reducing the dose of this medication when administered withvalproato.
It is not recommended to use oral risperidone with this medication as thiscombinationmayincreasethe risk of adverse effects.
Paliperidone TAD should be used with caution with medications that increase the activity of the central nervous system (psychoestimulants such asmethylphenidato).
Paliperidone withalcohol
You should avoid consuming alcohol during treatment with thismedicine.
Pregnancy andlactation
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using thismedicine.
You should not take this medication during pregnancy unless you have discussed it with yourmédico.
The following symptoms may occur in newborn babies of mothers who have been treated with paliperidone in the last trimester of pregnancy (last three months of pregnancy):temblor,rigidenessand/ormuscularweakness,somnolencess,problemswithbreating,anddifficultyinfeding.If your baby develops any of these symptoms, you should contact yourmédico.
You should not breastfeed your baby while taking this medication.
Driving andoperatingmachinery
During treatment with this medication, dizziness and vision problems (see section 4, Possible side effects) may occur. This should be taken into account when requiring high attention, for example, when driving oroperatingmachinery.
Paliperidone TAD contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Use in adults
The recommended dose in adults is 6 mg once a day in the morning. Your doctor may increase or decrease it within the dosing interval of 3 mg to 12 mg once a day in case of schizophrenia or 6 mg to 12 mg once a day in case of schizoaffective disorder. This depends on how well the medication works for you.
Use in adolescents and children
The recommended starting dose for the treatment of schizophrenia in adolescents aged 15 years or older is 3 mg once a day taken in the morning.
For adolescents weighing 51 kg or more, the dose can be increased within the interval of 6 mg to 12 mg once a day.
For adolescents weighing less than 51 kg, the dose can be increased to 6 mg once a day.
Your doctor will decide how much to administer to you. The amount you take depends on how well the medication works for you.
How and when to take paliperidone
This medication should be taken by mouth, swallowed whole with water or other liquids. Do not chew, break, or crush.
This medication should be taken in the mornings with breakfast or on an empty stomach, but in the same way every day. Do not alternate between taking the medication with breakfast and on an empty stomach the next day.
The active ingredient, paliperidone, dissolves once swallowed, and the coating of the tablet is eliminated from the body by the intestines.
Patients with kidney problems
Your doctor may adjust the dose of this medication according to your renal function.
Patients of advanced age
Your doctor may reduce your medication dose if your renal function is reduced.
If you take more paliperidone than you should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or go to the nearest hospital immediately, or call the Toxicological Information Service. Phone: 91 562 04 20 indicating the medication and the amount ingested. You may experience drowsiness, confusion, abnormal body movements, difficulty staying upright and walking, dizziness due to reduced blood pressure, and alterations in heartbeats.
If you forgot to take paliperidone
Do not take a double dose to compensate for the missed doses. If you forget a dose, take the next dose the next day. If you forget two or more doses, contact your doctor.
If you interrupt the treatment with paliperidone
Do not stop taking this medication as you will lose the effects of the medication. Do not stop taking this medication unless your doctor tells you to, as the symptoms may reappear.
If you have any other doubts about the use of this medication, ask your doctor or nurse.
Like all medicines, this medicine can cause side effects, althoughnotall people experience them.
Inform your doctor immediately if you experience any of the following:
Very common side effects: can affect more than 1 in 10 patients
Common side effects: can affect up to 1 in 10 patients
Rare side effects: can affect up to 1 in 1,000 patients
Unknown: their frequency cannot be estimated from the available data
The following side effects have appeared with the use of another medication called risperidone, which is very similar to paliperidone, so it is also expected to appear with paliperidone: eating disorder related to sleep, other types of blood vessel problems in the brain, crackling sounds from the lungs, and severe or life-threatening skin rash with blisters and peeling of the skin that can start in the mouth, nose, eyes, and genitals and spread to other parts of the body (Stevens-Johnson syndrome/toxic epidermal necrolysis). They may also appear eye problems during cataract surgery. During cataract surgery, there may be a change called intraoperative floppy iris syndrome (IFIS) if you are taking or have taken paliperidone. If you need to undergo cataract surgery, make sure to inform your ophthalmologist if you are taking or have taken this medication.
Additional side effects in adolescents
Adolescents generally experienced side effects similar to those found in adults, except for the following side effects that were detected more frequently:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
This medication does not require any special storage temperature.
Do not dispose of medications through drains or trash. Deposit empty containers and unused medications at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of empty containers and unused medications. This will help protect the environment.
Paliperidone TAD Composition
-The other components are:
Core: macrogol 200 000, macrogol 7 000 000, macrogol 4000, hydroxybutyltoluene, povidone, sodium chloride, microcrystalline cellulose, magnesium stearate, red iron oxide (E172), hydroxypropylcellulose and cellulose acetate.
Coating: hypromellose, titanium dioxide (E171), talc, propylene glycol, yellow iron oxide (E172) – only for 6 mg tablets and red iron oxide (E172) – only for 9 mg tablets.
Printed ink: shellac, black iron oxide (E172) and propylene glycol. See section 2 “Paliperidone TAD contains sodium”.
Appearance of the product and contents of the pack
3 mg: Film-coated, biconvex, round, white to off-white tablets with a possible irregular surface and printed with the mark P3 on one side of the tablet. Diameter: approximately 9 mm.
6 mg: Film-coated, biconvex, round, yellowish-brown tablets with a possible irregular surface and printed with the mark P6 on one side of the tablet. Diameter: approximately 9 mm.
9 mg: Film-coated, biconvex, round, pale pink tablets with a possible irregular surface and printed with the mark P9 on one side of the tablet. Diameter: approximately 9 mm.
Paliperidone TAD are available in packs of 14x1, 28x1 and 56x1 prolonged-release tablets in blister packs.
Only some pack sizes may be marketed.
Marketing Authorization Holder
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
Manufacturer
KRKA d.d. Novo mesto
Smarjeska cesta 6
8501 Novo mesto
Slovenia
You can obtain more information about this medicinal product by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, 28108 Alcobendas, Madrid, Spain
This medicinal product is authorized in the Member States of the European Economic Area with the following names:
Member State | Medicinal Product Name |
Hungary | Paliperidon Krka 3 mg retard tabletta Paliperidon Krka 6 mg retard tabletta Paliperidon Krka 9 mg retard tabletta |
Belgium | Paliperidon Krka 3 mg tabletten met verlengde afgifte Paliperidon Krka 6 mg tabletten met verlengde afgifte Paliperidon Krka 9 mg tabletten met verlengde afgifte |
Cyprus | Paliperidon TAD |
Denmark | Paliperidon Krka |
Spain | Paliperidona TAD 3 mg prolonged-release tablets EFG Paliperidona TAD 6 mg prolonged-release tablets EFG Paliperidona TAD 9 mg prolonged-release tablets EFG |
Iceland | Paliperidon Krka 3 mg forðatöflur Paliperidon Krka 6 mg forðatöflur Paliperidon Krka 9 mg forðatöflur |
Italy | Paliperidone Krka |
Ireland | Paliperidon TAD |
Sweden | Paliperidon Krka 3 mg depottabletter Paliperidon Krka 6 mg depottabletter Paliperidon Krka 9 mg depottabletter |
Last revision date of this leaflet:April 2024
Further information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.